^
    Back
    Association details:
    Biomarker:EGFR E746_S752delinsV
    Cancer:Lung Non-Small Cell Squamous Cancer
    Drug:gefitinib (EGFR inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C4 – Case Studies
    Source:
    Dovepress
    Title:

    Clinical and Pathologic Complete Response to Gefitinib in a Patient with SqCLC Harboring EGFR p.E746_S752delinsV Mutation

    Published date:
    09/15/2021
    Excerpt:
    In the present study, we describe a case of treatment-naïve stage IIIB SqCLC that harbored a rare epidermal growth factor receptor (EGFR) p.E746_S752delinsV mutation with clinical complete response to neoadjuvant gefitinib.
    DOI:
    https://doi.org/10.2147/OTT.S328839